Furthermore, our finding that the proportion of tumor cells expressing IGF-1 was also increased in one of two plasma cell-like clusters post-vaccine suggests that clonal selection of IGF signaling-dependent tumor clones cannot be excluded (Fig. S3P). The gene discussed is IGF1; the disease is neoplasm.